Elevai Labs Overview
Elevai Labs (ELAB) has a ROE of 13.47%, below the Consumer Discretionary sector average of 14.05%.
Get informed when a big investor buys or sells
+ Follow13.47%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for ELAB is 13.47%. That is below the Consumer Discretionary sector average of 14.05%. Investors often review this figure alongside Elevai Labs's historical trend and sector peers before judging valuation or financial health.
Against Consumer Discretionary companies, ELAB currently prints 13.47% for ROE, while the sector average sits near 14.05%. That is roughly 4.1% below the sector mean. Large gaps often invite a closer look at Elevai Labs's growth, margins, and balance sheet.
Return on Equity shows how effectively Elevai Labs converts resources into returns. At 13.47%, ELAB may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ELAB's ROE (13.47%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Elevai Labs's ROE against similar Consumer Discretionary names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Discretionary companies and their key multiples and fundamentals.
